Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple phone call keep you out of the ER?

NCT ID NCT07207499

Knowledge-focused Sponsor: University Hospital, Rouen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test a new phone-based healthcare access service (SAS) in Le Havre, France, designed to direct non-emergency callers to primary care instead of the emergency room. Researchers will compare ER visit rates between callers using the new system and those using the standard phone triage. Over 9,000 calls will be analyzed to see if the SAS reduces unnecessary ER visits and improves patient care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Healthcare Access Service (SAS) - a telephone triage system that directs callers to primary care or emergency services
What this could lead to
If successful, this could show that a coordinated phone triage system reduces unnecessary emergency room visits and improves patient flow.
What could go wrong
This is an observational study, not a treatment trial. Results may not apply to other regions, and the system's effectiveness depends on local healthcare resources.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 9,280 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2025

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Users of the health system: The concept of users applies not only to the sick person and their loved ones but, more broadly, to any actual or potential user of the health system, in the health and medico-social fields, in establishments as well as in outpatient care or in home care

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * For the primary analysis and secondary outcome measure 1: * All calls to 116-117 or 15 in the Le Havre area over the 40 study periods, * Non-opposition. Patients with a life-threatening emergency will be included in the primary analysis, even though there will be no pseudo-randomization of the systems for them. They are therefore included in the study. * For the secondary analysis on patient compliance with the referral given by the regulating physician (secondary objective 2): * Non-opposition of patients who used the SNP call for the primary analysis, * Randomly selected by sampling calls to 116-117 or 15 made over the study periods defined by the protocol. * For the qualitative component: * Major, * No opposition from regulators and major effectors of the SAS * Or No opposition from adult health patients in the Le Havre area who have used the unscheduled care system (outpatient or inpatient). Exclusion Criteria: * For the primary analysis and secondary objective 1: * Refusal to participate, * Non-French speaking. * For the secondary analysis on patient compliance with the referral given by the regulating physician (secondary objective 2) and for the qualitative component: * Minor caller * Refusal to participate (patient or caller or both), * Non-French speaking (caller) * Only for adult healthcare users in the Le Havre area included in the qualitative component: Not having the independent capacity to use the SNP. Non-use of the SAS will not be a criterion for exclusion.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Emergency service, hospital are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Emergencies

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Emergency service, hospital

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Le Havre Hospital Group,

    Le Havre, 76083, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.